ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test

By Sahil Pandey June 24 (Reuters) - ALZpath said on Wednesday it had signed a global licensing agreement with Abbott ...
Chicago Tribune

Abbott’s COVID-19 test sales dive by nearly 90%

Abbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop that comes as the world attempts to move on ...
Forbes

Abbott Labs Reports $1 Billion Profit Despite Falling Covid Test Sales

The Abbott Laboratories logo is displayed at the company's booth during the Consumer Electronics Show (CES) on January 5, 2022 in Las Vegas, Nevada. (Photo by Patrick T. FALLON / AFP) (Photo by ...
Hosted on MSN

Abbott Narrows Its Outlook as COVID-19 Testing Demand Wanes. Its Stock Is Falling.

Abbott Laboratories narrowed its full-year outlook as sales of COVID-19 tests slide. COVID-19 test sales in the second quarter dropped 46% from the year before. Second-quarter earnings and revenue ...
Nasdaq

Abbott (ABT) Gets FDA Nod for Alinity I Laboratory Test

Abbott Laboratories, Inc. ABT recently announced the receipt of the FDA approval for the Alinity i laboratory traumatic brain injury (TBI) blood test. This will be the first commercially available TBI ...
The Business Journals

Abbott Labs performing well despite huge drop-off in Covid test sales

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The North Chicago company said ...
FierceBiotech

Abbott's lab-based blood test for concussion scores FDA nod

Abbott's lab-based concussion test looks for two biomarkers in the blood, both of which have been closely linked to traumatic brain injuries when found in elevated concentrations. In studies, it was ...
Crain's Chicago Business

Abbott concussion test OK'd for bedside application

A concussion test that Abbott Labs hopes someday could be used by sports team trainers and at urgent care clinics is now available for rapid use at the bedside, without having to send a sample to a ...
CNBC

Abbott Labs shares pop as revenue, earnings defy steep drop in Covid test sales

Shares of Abbott Laboratories popped after the company's earnings and revenue topped Wall Street estimates, defying a dramatic slowdown in sales of its Covid tests. The results were driven in part to ...
Forbes

Abbott Is Bouncing Back From Baby Formula Problems And Lost Covid Test Sales

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories is rebounding from last year’s manufacturing ...
The Motley Fool

Is Abbott Laboratories Stock a Buy Now?

On Jan. 24, Abbott posted its year-end and fourth-quarter numbers for the last three months of 2023. Revenue in Q4 rose by 1.5% year over year to $10.2 billion, but on an organic basis and when ...